Lupin Financial and Company Overview
Other Markets: Key Highlights
Other Key Markets driving growth
Emerging Markets: Steady growth
EU
EU
Successful MHRA inspection of
Pithampur facilities
Acquired Medisol in France -
unique hospital business
Brazil
BRL 75 mn sales in Q4 FY23
(growth 24% LCL YoY);
In reference market, ranks 10th
position in value terms³
8th largest generics player¹
Market leader in Ophthal (#2 in
South Africa
35% QoQ growth to reach ZAR 417
mn sales in Q4 FY23
Mexico
units and #5 in value)³
AN
4th largest generics player²
Australia
SCP acquisition performing well
API + Global
Institutional
Note:
1. IQVIA Feb23 by sales
2. IQVIA Midas Sales Audit Dec-22
•
Strong QoQ growth of 20%
Philippines
Q4FY23 to reach PHP542 mn
API revenues grew 46% QoQ in Q4 FY23 due to core API business growth
Continued leadership in anti-TB Institutional business and increased ARV presence
3. IQVIA MAT Jan-23
LUPIN
11View entire presentation